Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea · Delayed Price · Currency is KRW 5,100.00
+50.00 (0.99%)
At close: Aug 24, 2026
Kyung Dong Pharmaceutical Market Cap
Kyung Dong Pharmaceutical has a market cap or net worth of 136.06 billion as of August 24, 2026. Its market cap has decreased by -14.12% in one year.
Market Cap
136.06B
Enterprise Value
132.72B
Revenue
198.27B
Ranking
n/a
PE Ratio
11.85
Stock Price
5,100.00
ChartMarket Cap Chart
Since January 29, 2001, Kyung Dong Pharmaceutical's market cap has increased from 44.35B to 136.06B, an increase of 206.76%. That is a compound annual growth rate of 4.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 136.06B | -13.53% |
| Dec 30, 2025 | 157.34B | -4.73% |
| Dec 30, 2024 | 165.15B | -7.92% |
| Dec 28, 2023 | 179.35B | -16.01% |
| Dec 29, 2022 | 213.54B | -31.89% |
| Dec 30, 2021 | 313.54B | 1.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 185.44B |
| DAE HWA Pharmaceutical | 178.32B |
| Cosmax Nbt | 165.67B |
| CellBion | 165.06B |
| GC WellBeing | 151.01B |
| PHARMARESEARCH BIO | 131.48B |
| High Tech Pharm | 124.62B |
| HYUNDAI BIOLAND | 120.75B |